APA (7th ed.) Citation

McKinzie, D. L., May, P. C., Boggs, L. N., Yang, Z., Brier, R. A., Monk, S. A., . . . Mergott, D. J. (2016). NONCLINICAL PHARMACOLOGICAL CHARACTERIZATION OF THE BACE1 INHIBITOR LY3202626. Alzheimer's & dementia, 12(7), P432-P433. https://doi.org/10.1016/j.jalz.2016.06.828

Chicago Style (17th ed.) Citation

McKinzie, David L., et al. "NONCLINICAL PHARMACOLOGICAL CHARACTERIZATION OF THE BACE1 INHIBITOR LY3202626." Alzheimer's & Dementia 12, no. 7 (2016): P432-P433. https://doi.org/10.1016/j.jalz.2016.06.828.

MLA (9th ed.) Citation

McKinzie, David L., et al. "NONCLINICAL PHARMACOLOGICAL CHARACTERIZATION OF THE BACE1 INHIBITOR LY3202626." Alzheimer's & Dementia, vol. 12, no. 7, 2016, pp. P432-P433, https://doi.org/10.1016/j.jalz.2016.06.828.